Advances in kidney disease: pathogenesis and therapeutic targets
Chronic kidney disease (CKD) is a global public health issue characterized by progressive loss of kidney function, of which end-stage kidney disease (ESKD) is the last stage. The global increase in the prevalence of CKD is linked to the increasing prevalence of traditional risk factors, including ob...
Saved in:
| Main Authors: | Vincent Boima, Alex Baafi Agyekum, Khushali Ganatra, Francis Agyekum, Edward Kwakyi, Jalil Inusah, Elmer Nayra Ametefe, Dwomoa Adu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1526090/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1–Mediated Kidney Disease (JUSTICE)
by: Opeyemi A. Olabisi, et al.
Published: (2024-09-01) -
Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell Injury
by: Razi Khalaila, et al.
Published: (2025-07-01) -
A Cell Biologist’s View on APOL1: What We Know and What We Still Need to Address
by: Verena Höffken, et al.
Published: (2025-06-01) -
APOL4-mediated intracellular cholesterol trafficking is essential for glioblastoma cell growth
by: Mingxiang Zhang, et al.
Published: (2025-05-01) -
HIV-1 Nef synergizes with APOL1-G1 to induce nephrocyte cell death in HIV-related kidney diseases
by: Jun-yi Zhu, et al.
Published: (2025-07-01)